"Untreatable" neuromuscular disease. Treatment trials and symptomatic treatment of amyotrophic lateral sclerosis.
D000690:Amyotrophic Lateral Sclerosis / Q000209:etiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D009467:Neuromuscular Depolarizing Agents / Q000627:therapeutic use; D010447:Peptide Hydrolases / Q000378:metabolism
D009467:Neuromuscular Depolarizing Agents; D010447:Peptide Hydrolases